- Ranking puts Fresenius Medical Care among the best-in-class
sustainability performers in the world and Europe
- The company recorded progress towards its sustainability
targets
- Sustainability is one of the essential drivers for future
BAD HOMBURG, Germany, Dec. 23,
2024 /PRNewswire/ -- Fresenius Medical
Care (FME), the world's leading provider of products and
services for individuals with renal diseases, has been recognized
as a sustainability leader with the inclusion in the Dow Jones
Sustainability World Index and with the inclusion in the Dow
Jones Sustainability Europe Index for the 15th
time. Dow Jones Sustainability Index (DJSI) is one of the
world's leading ESG (Environmental, Social, Governance) stock
indices.
Helen Giza, CEO of Fresenius
Medical Care AG, said: "We believe that sustainability and
excellent patient care are inextricably linked. I am very proud
that our employees' commitment to our sustainability efforts has
been recognized through the inclusion in the indices. Considering
sustainability in our products and the way we work helps to ensure
that we provide excellent, high-quality services for future
generations."
Fresenius Medical Care continuously incorporates sustainability
into its global business operations. The company's approach centers
on three strategic focus areas:
- Enhancing quality of care and access to healthcare,
- building the best teams to serve patients, and
- reducing the company's environmental footprint.
In 2023, FME has reported progress toward its sustainability
targets and governance:
- Fresenius Medical Care improved its Net Promoter Score to 72,
reflecting a high patient satisfaction with its services.
- The company increased the share of women in the top two
management levels below Management Board to 34%, underlining its
commitment to diversity, equity and inclusion.
- FME moved ahead with its climate neutrality action plan, with
Scope 1 and 2 emissions in 2023 decreasing by 16% from a 2020
baseline. The reduction of CO2e emissions is included in
the targets for the long-term compensation of the Management Board
members for 2024.
- In 2024 the company signed five virtual power purchase
agreements for approximately 580 gigawatt hours per year with wind
and solar farms in Germany and the
U.S. It also submitted the commitment letter to the Science Based
Target initiative (SBTi).
The Dow Jones Sustainability Indices are the longest-running
global sustainability benchmarks. Each year, over 13,000 companies
are invited to participate in the Corporate Sustainability
Assessment (CSA). Approximately 3,500 of the largest companies
worldwide are eligible for inclusion in any DJSI. The annual review
evaluates companies' sustainability performance in areas relevant
to each industry.
An overview of Fresenius Medical Care's progress in
sustainability can be found in the company's non-financial group
report here.
About Fresenius Medical Care:
Fresenius Medical Care is the world's leading provider of products
and services for individuals with renal diseases of which around
4.1 million patients worldwide regularly undergo dialysis
treatment. Through its network of 3,732 dialysis clinics, Fresenius
Medical Care provides dialysis treatments for approx. 308,000
patients around the globe. Fresenius Medical Care is also the
leading provider of dialysis products such as dialysis machines or
dialyzers. Fresenius Medical Care is listed on the Frankfurt Stock
Exchange (FME) and on the New York Stock Exchange (FMS).
For more information visit the company's website
at www.freseniusmedicalcare.com.
Disclaimer:
This release contains forward-looking statements that are subject
to various risks and uncertainties. Actual results could differ
materially from those described in these forward-looking statements
due to various factors, including, but not limited to, changes in
business, economic and competitive conditions, legal changes,
regulatory approvals, impacts related to the COVID-19 pandemic
results of clinical studies, foreign exchange rate fluctuations,
uncertainties in litigation or investigative proceedings, and the
availability of financing. These and other risks and uncertainties
are detailed in Fresenius Medical Care's reports filed with the
U.S. Securities and Exchange Commission. Fresenius Medical Care
does not undertake any responsibility to update the forward-looking
statements in this release.
Media contact
Christine
Peters
T +49 160 60 66 770
christine.peters@freseniusmedicalcare.com
Contact for analysts and investors
Dr. Dominik Heger
T +49 6172 609 2601
dominik.heger@freseniusmedicalcare.com
www.freseniusmedicalcare.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/fresenius-medical-care-listed-in-the-dow-jones-sustainability-world-index-and-for-the-15th-time-in-the-dow-jones-sustainability-europe-index-302338375.html
SOURCE Fresenius Medical Care Holdings, Inc.